Presentations, Including Combination Therapy with HMAs, in Patients with Acute Myeloid
Leukemia at ASH Annual Meeting 56
Dec 05, 2016: BioLineRx Presents Positive Phase 2a AML Study and Mechanism-of-Action Data for
BL-8040 Oncology Platform at ASH 2016 57
Dec 05, 2016: Preclinical Data on IMGN632, a Novel CD123-Targeting ADC, Presented at ASH
Annual Meeting 58
Dec 05, 2016: Helsinn Group and MEI Pharma Report Prolongation of Survival Results from Phase
2 Clinical Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia 58
Dec 05, 2016: Syros Pharmaceuticals Presents Data at ASH Annual Meeting Further Supporting
Clinical Potential of Its First-in-Class Selective RARa Agonist for Genomically Defined Subsets of
AML and MDS Patients 59
Dec 05, 2016: Actinium Highlights Results from Phase 1 Clinical Trial of Actimab-A at 58th
American Society of Hematology Annual Meeting 60
Dec 05, 2016: Onconova Presents Phase 2 Data from Oral Rigosertib and Azacitidine Combination
Trial in Higher-Risk Myelodysplastic Syndromes (HR-MDS) at 2016 ASH Annual Meeting 60
Dec 05, 2016: Cornerstone Pharmaceuticals Presents Phase I Data on CPI-613 in Acute Myeloid
Leukemia (AML) and T-Cell Non-Hodgkin Lymphoma (T-cell NHL) at ASH 2016 61
Dec 05, 2016: ORYZON Announces Encouraging Top-line Results from Phase I-IIA Clinical Trial
in Acute Leukemia of RG6016 (ORY-1001) at the American Society of Hematology 2016 Annual
Meeting 62
Dec 04, 2016: Karyopharm Presents Updated Phase 2 SAIL Relapsed/Refractory AML Clinical Data
at the American Society of Hematology 2016 Annual Meeting 63
Dec 03, 2016: New Phase 2 Results Show Investigational Compound Glasdegib Improved Overall
Survival in Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome 64
Dec 03, 2016: Seattle Genetics Presents Phase 1b Data from Vadastuximab Talirine (SGN-CD33A;
33A) in Combination with Standard of Care in Frontline Acute Myeloid Leukemia at ASH Annual
Meeting 64
Dec 03, 2016: Trillium Presents Initial Data From Ongoing Study of TTI-621 in Patients With
Advanced Hematologic Malignancies